NTRB: רווח למניה בשנים עשר החודשים האחרונים Nutriband Inc

Nutriband Inc. (NTRB) is focusing on the implementation of the Aversa system for patch protection, awaiting FDA approval to capture the market. The company's net profit per share over 12 months reflects asset dynamics, where -0.59 characterizes this valuation parameter. Automated production ensures high scalability of output, while unique opioid protection creates sustainable customer loyalty within the niche ecosystem.
Nutriband Inc. (NTRB) - פילוחי מדדים ודוחות פיננסיים

Nutriband Inc. operates amid intense patent disputes and pressure from generic manufacturers. The TTM net income per share reflects the business's total trailing twelve-month profitability divided by the total number of outstanding securities. Investors utilize this metric to evaluate the monetization efficiency of transdermal technologies. The calculation trend reveals the company's scaling pace within a competitive environment. The current trend in TTM net income per share visualizes the actual return on innovation.